Market Overview

US Stock Futures Edge Higher Ahead Of Fed Minutes, Alcoa Earnings

US Stock Futures Edge Higher Ahead Of Fed Minutes, Alcoa Earnings

Pre-open movers

US stock futures traded slightly higher in early pre-market trade. The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET. Alcoa Inc. (NYSE: AA) is projected to post its Q1 earnings after the closing bell. Futures for the Dow Jones Industrial Average gained 10.50 points to 17,795.50, while the Standard & Poor's 500 index futures surged 1.40 points to 2,069.15. Futures for the Nasdaq 100 index rose 1.20 points to 4,335.20.

A Peek Into Global Markets

European markets were mostly lower today, with the Spanish Ibex Index falling 0.46%, STOXX Europe 600 Index surging 0.18% and German DAX 30 index falling 0.49%. French CAC 40 Index slipped 0.15% and London's FTSE 100 Index rose 0.54%.

In Asian markets, Japan's Nikkei Stock Average rose 0.76%, China's Shanghai Composite Index jumped 0.84%, Hong Kong's Hang Seng Index climbed 3.80% and India's BSE Sensex gained 0.67%.

Broker Recommendation
Analysts at Barclays upgraded Visteon Corporation (NYSE: VC) from Equal-weight to Overweight and raises the price target from $107.00 to $121.00.

Visteon shares fell 0.25% to close at $98.16 yesterday.

Breaking news

  • Dyax Corp. (NASDAQ: DYAX) today announced the pricing of an underwritten public offering of 7,400,000 shares of its common stock, offered at a price to the public of $27.00 per share. To read the full news, click here.
  • The Boards of Shell (NYSE: RDS-A)(NYSE: RDS-B) and BG (OTC: BRGYY) are pleased to announce that they have reached agreement on the terms of a recommended cash and share offer to be made by Shell for the entire issued and to be issued share capital of BG. To read the full news, click here.
  • Gilead Sciences, Inc. (NASDAQ: GILD) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for two doses of an investigational fixed-dose combination of emtricitabine and tenofovir alafenamide (200/10 mg and 200/25 mg) (F/TAF) for the treatment of HIV-1 infection in adults and pediatric patients age 12 years and older, in combination with other HIV antiretroviral agents. To read the full news, click here.
  • CareTrust REIT, Inc. (NASDAQ: CTRE) today announced that it has acquired Mira Vista Care Center, a 94-bed skilled nursing facility located in Mount Vernon, Washington, for $9.1 million. To read the full news, click here.

Posted-In: Barclays US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AA + BRGYY)

View Comments and Join the Discussion!

Advaxis, Merck Report Initiation of Enrollment in Phase 1/2 Study of ADXS-PSA in Combo with Anti-PD-1 Therapy

A Nuclear Energy ETF To Look At Amid Iran Agreement